Announcements Trials

Browse Landscape

Status

Completed 5 Unknown 3 Terminated 3 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 18 Gastrointestinal 15 Gynecologic 10 Genitourinary 10 Head & Neck 9 Thoracic 5 CNS 5 Tumor-Agnostic 4 Plasma cell 2 Other solid neoplasm 2 Other hematologic neoplasm 2 Lymphoid 2 Other neoplasm 1 Other 1 Myeloid 1 Endocrine 1 Dermatologic 1

Conditions

Myeloproliferative Disorders 1

Interventions

fludarabine 23 Cyclophosphamide 23 fludarabine phosphate 18 Tacrolimus 16 ruxolitinib 15 Melphalan 15 Azacitidine 14 venetoclax 13 Whole-Body Irradiation 12 Mycophenolic Acid 12 Cytarabine 11 Busulfan 11 Thiotepa 9 Specimen Handling 9 Stem Cell Transplantation 8 Granulocyte Colony-Stimulating Factor 8 Decitabine 8 Biopsy 8 Peripheral Blood Stem Cell Transplantation 7 Imatinib Mesylate 7 decitabine and cedazuridine drug combination 6 Sirolimus 6 Methotrexate 6 thymoglobulin 5 nilotinib 5 X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Injections 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Surveys and Questionnaires × Myeloid × Clear all

NCT04378855 2025-09-23

PROPHECY

Gruppo Italiano Malattie EMatologiche dell'Adulto

Active not recruiting

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡